Zelquistinel

DRUG3 trials

Sponsors

Syndeio Biosciences, Inc

Conditions

Major Depressive Disorder

Phase 1

Safety and Tolerability of Zelquistinel in Normal Human Volunteers

CompletedNCT04981561

Syndeio Biosciences, IncMajor Depressive Disorder

Start: 2016-12-09End: 2017-12-21Updated: 2026-03-12

Phase 2

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

RecruitingNCT06547489

Syndeio Biosciences, IncMajor Depressive Disorder

Start: 2025-02-03End: 2027-12-01Target: 164Updated: 2026-08-03

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

RecruitingNCT07115329

Syndeio Biosciences, IncMajor Depressive Disorder

Start: 2026-01-05End: 2028-06-01Target: 164Updated: 2026-07-27